title: Prevention and management of COPD in China: successes and major challenges.
authors.affiliation: State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, Guangdong 510120, China.
authors.forename: Wei-Jie
authors.initials: WJ
authors.lastname: Guan
authors.affiliation: State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, Guangdong 510120, China.
authors.forename: Pi-Xin
authors.initials: PX
authors.lastname: Ran
authors.affiliation: State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, Guangdong 510120, China. Electronic address: nanshan@vip.163.com.
authors.forename: Nan-Shan
authors.initials: NS
authors.lastname: Zhong
mesh_terms: D000328:Adult; D000368:Aged; D000393:Air Pollutants / Q000009:adverse effects; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002681:China / Q000453:epidemiology; D003131:Combined Modality Therapy; D019468:Disease Management; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011322:Primary Prevention / Q000379:methods*; D029424:Pulmonary Disease, Chronic Obstructive / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy*; D012138:Respiratory Therapy / Q000379:methods; D018570:Risk Assessment; D012720:Severity of Illness Index; D012907:Smoking / Q000009:adverse effects
chemical_list: D000393:Air Pollutants; D001993:Bronchodilator Agents